These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 35652594)

  • 21. Two-year study on the application of the Paris system for urinary cytology in a cancer centre.
    de Paula R; Oliveira A; Nunes W; Bovolim G; Domingos T; De Brot L; Bezerra S; Cunha I; Morini M; Saieg M
    Cytopathology; 2020 Jan; 31(1):41-46. PubMed ID: 31654587
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Application of The Paris System to atypical urine cytology samples: correlation with histology and UroVysion
    Miki Y; Neat M; Chandra A
    Cytopathology; 2017 Apr; 28(2):88-95. PubMed ID: 27601215
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the Paris System in atypical urinary cytology.
    Mikou P; Lenos M; Papaioannou D; Vrettou K; Trigka EA; Sousouris S; Constantinides C
    Cytopathology; 2018 Dec; 29(6):545-549. PubMed ID: 30066427
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of conventional and liquid-based cytology using The Paris System for Reporting Urinary Cytology.
    Goutas D; Savvidou K; Vrettou K; Meletis E; Levis P; Constantinides C; Lazaris AC; Mikou P
    Cytopathology; 2021 Nov; 32(6):795-801. PubMed ID: 34289188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. One year of experience using the Paris System for Reporting Urinary Cytology.
    Meilleroux J; Daniel G; Aziza J; d'Aure DM; Quintyn-Ranty ML; Basset CM; Evrard SM; Courtade-Saidi MM
    Cancer Cytopathol; 2018 Jun; 126(6):430-436. PubMed ID: 29663682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Paris System for Reporting Urinary Cytology reduces atypia rates and does not alter the negative predictive value of urine cytology.
    McIntire PJ; Kilic I; Pambuccian SE; Wojcik EM; Barkan GA
    J Am Soc Cytopathol; 2021; 10(1):14-19. PubMed ID: 33221245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Applicability of the Paris System for veterans: high rates of undiagnosed low-grade urothelial neoplasia.
    Chandler JB; Colunga M; Celli R; Lithgow MY; Baldassarri RJ
    J Am Soc Cytopathol; 2021; 10(4):357-365. PubMed ID: 33849782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of Implementing the Paris System for Reporting Urine Cytology in the Performance of Urine Cytology:  A Correlative Study of 124 Cases.
    Hassan M; Solanki S; Kassouf W; Kanber Y; Caglar D; Auger M; Brimo F
    Am J Clin Pathol; 2016 Sep; 146(3):384-90. PubMed ID: 27543983
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implementing The Paris System for Reporting Urinary Cytology results in a decrease in the rate of the "atypical" category and an increase in its prediction of subsequent high-grade urothelial carcinoma.
    Wang Y; Auger M; Kanber Y; Caglar D; Brimo F
    Cancer Cytopathol; 2018 Mar; 126(3):207-214. PubMed ID: 29278461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Application of the Paris Reporting System for Urine Cytology: The Three-Year Experience of a Single Tertiary Care Institute in Thailand.
    Phruttinarakorn B; Plumworasawat S; Kayankarnnavee J; Lualon J; Pongtippan A
    Acta Cytol; 2022; 66(2):134-141. PubMed ID: 34999581
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative cytomorphological comparison of SurePath and ThinPrep liquid-based cytology using high-grade urothelial carcinoma cells.
    Okuda C; Kyotake A; Nakamura A; Itoh T; Kamoshida S; Ohsaki H
    Cytopathology; 2021 Sep; 32(5):654-659. PubMed ID: 34033150
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urine cytology findings in patients with biopsy-confirmed urothelial carcinoma in situ with plasmacytoid features.
    Nichols MM; Reynolds JP; McKenney JK; Nicolas MM; McIntire PJ; Policarpio-Nicolas MLC
    Cancer Cytopathol; 2021 Oct; 129(10):798-804. PubMed ID: 33900681
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved correlation of urinary cytology specimens using The Paris System in biopsy-proven upper tract urothelial carcinomas.
    McIntire PJ; Snow JT; Robinson BD; Rao RA; Goyal A; Heymann JJ; Siddiqui MT
    Cancer Cytopathol; 2018 Jul; 126(7):498-504. PubMed ID: 29927548
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experience on the use of The Paris System for Reporting Urinary Cytopathology: review of the published literature.
    Pastorello RG; Barkan GA; Saieg M
    J Am Soc Cytopathol; 2021; 10(1):79-87. PubMed ID: 33160893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Significant reduction of indeterminate (atypical) diagnosis after implementation of The Paris System for Reporting Urinary Cytology: A single-institution study of more than 27,000 cases.
    Tian W; Shore KT; Shah RB
    Cancer Cytopathol; 2021 Feb; 129(2):114-120. PubMed ID: 32931158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improved risk stratification for patients with high-grade urothelial carcinoma following application of the Paris System for Reporting Urinary Cytology.
    Cowan ML; Rosenthal DL; VandenBussche CJ
    Cancer Cytopathol; 2017 Jun; 125(6):427-434. PubMed ID: 28272842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Practical application of the Paris system for reporting urinary cytology].
    Chen L; Liu LT; Sun MJ; He SR; Liu DG
    Zhonghua Bing Li Xue Za Zhi; 2024 May; 53(5):470-476. PubMed ID: 38678328
    [No Abstract]   [Full Text] [Related]  

  • 38. Impact of implementing the first edition of the Paris system for reporting: A systematic review and meta-analysis.
    Farahani SJ; Li J; Minder B; Vielh P; Glisic M; Muka T
    Cytopathology; 2024 Sep; 35(5):616-633. PubMed ID: 38934101
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The inclusion of nuclear area improves the Paris system for reporting urinary cytology.
    Tanaka S; Naritomi M; Monobe Y; Ariyasu S
    Cytopathology; 2023 Mar; 34(2):106-112. PubMed ID: 36336883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Digital image analysis supports a nuclear-to-cytoplasmic ratio cutoff value below 0.7 for positive for high-grade urothelial carcinoma and suspicious for high-grade urothelial carcinoma in urine cytology specimens.
    McIntire PJ; Snow JT; Elsoukkary SS; Soong L; Sweeney J; Robinson BD; Siddiqui MT
    Cancer Cytopathol; 2019 Feb; 127(2):120-124. PubMed ID: 30395388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.